泛素特異性蛋白酶28抗體 返回列表頁(yè)

泛素特異性蛋白酶28抗體

英文名稱 USP28
中文名稱 泛素特異性蛋白酶28抗體
別    名 Deubiquitinating enzyme 28; KIAA1515; Ubiquitin carboxyl terminal hydrolase 28; Ubiquitin carboxyl-terminal hydrolase 28; Ubiquitin specific peptidase 28; Ubiquitin specific processing protease 28; Ubiquitin specific protease 28; Ubiquitin thioesterase 28; Ubiquitin thiolesterase 28; Ubiquitin-specific-processing protease 28; UBP28_HUMAN; USP 28; USP28; USP28 protein.
 
說(shuō) 明 書 0.2ml  
研究領(lǐng)域 腫瘤  細(xì)胞生物  免疫學(xué)  染色質(zhì)和核信號(hào)  
抗體來(lái)源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 75, 100kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human USP28
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
生 產(chǎn) 商 BIOSS
PubMed PubMed
產(chǎn)品介紹 background:
Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus.

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or xy-0134R    Nogo-A軸索過(guò)度生長(zhǎng)抑制因子-A抗體
xy-0156R    nNos/一氧化氮合成酶-1抗體（神經(jīng)型）
xy-0163R    eNOS一氧化氮合成酶-3（內(nèi)皮型）抗體
xy-0181R    Nociceptin receptor孤菲肽受體/痛敏肽受體抗體
xy-0448R    NIS鈉碘轉(zhuǎn)運(yùn)體蛋白抗體
xy-0064R    Neurokinin 1 ReceptorP物質(zhì)受體抗體
xy-0166R    Neurokin B receptor神經(jīng)激肽B受體抗體
xy-0688R    Nm23腫瘤轉(zhuǎn)移抑制基因抗體
xy-1066R    NME1腫瘤抑制基因抗體
xy-1073R    Nm23-H2腫瘤抑制基因抗體
xy-0075R    Nociceptin孤菲肽/痛敏肽抗體
xy-0129R    Nogo R軸索過(guò)度生長(zhǎng)抑制因子受體/Nogo受體抗體
xy-12151R    NAV3神經(jīng)元引導(dǎo)蛋白3抗體
xy-10027R    NCR1細(xì)胞毒性受體NK-p46抗體
xy-12146R    Neurabin 2神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體
xy-9320R    NYS48NYS48蛋白抗體
xy-9331R    NHLRC1肌痙攣性癲癇病相關(guān)EPM2蛋白抗體
xy-9332R    NHLRC2非霍奇金淋巴瘤重復(fù)蛋白2抗體
xy-0323R    NMDAR2C谷氨酸受體2C抗體（N端）
xy-6855R    NALP4癌/睪丸抗原58抗體
xy-9333R    NHLRC3非霍奇金淋巴瘤重復(fù)蛋白3抗體
xy-9710R    NOP2增殖相關(guān)核仁抗原抗體
xy-6864R    NALP12NALP12抗體
xy-6865R    NALP6富含亮氨酸重復(fù)結(jié)構(gòu)域蛋白6抗體
xy-6866R    NLRP7富含亮氨酸重復(fù)結(jié)構(gòu)域蛋白7抗體
xy-6867R    NLRP9富含亮氨酸重復(fù)結(jié)構(gòu)域蛋白9抗體
xy-6856R    NLRP10富含亮氨酸重復(fù)結(jié)構(gòu)域蛋白10抗體
xy-1997R    NCX2鈉鈣交換蛋白2抗體
xy-1998R    NDRG2抑癌基因NDRG2抗體
xy-2400R    MDC1DNA損傷關(guān)卡蛋白1抗體
xy-2401R    Nebulin伴肌動(dòng)蛋白抗體
xy-1999R    NDRG4抑癌基因NDRG4抗體
xy-2411R    NKG2ANK細(xì)胞受體2A抗體